To investigate the importance of DYRK1A in cognitive deficits shown by transgenic mouse models of DS, we used a series of low molecular weight pharmacological inhibitors, collectively known as leucettines (Debdab et al., 2011; Tahtouh et al., 2012; T. Tahtouh, unpublished). This evidence concerns the gene DYRK1A and Dravet syndrome.